STAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response
Open Access
- 1 September 2011
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 187 (5), 2578-2585
- https://doi.org/10.4049/jimmunol.1004128
Abstract
Type I IFNs are crucial cytokines of innate immunity for combating viral infections. Signaling through type I IFN receptors triggers the activation of STAT proteins, including STAT1, STAT2, and STAT3. Although an essential role of STAT1 and STAT2 for type I IFN-induced antiviral response has been well established by studies of gene-targeted mice and human mutations, the role of STAT3 for this response remains unclear. Using gain-of-function and loss-of-function approaches, we demonstrated that STAT3 negatively regulates type I IFN-mediated response. STAT3 knockdown or knockout cells displayed enhanced gene expression and antiviral activity in response to IFN-α/β. Restoration of STAT3 to STAT3KO cells resulted in attenuation of the response. Upon viral infection, increased type I IFN production in STAT3KO cells resulted in enhanced STAT activation and ISG expression. One mechanism for the enhanced IFN production and response in the absence of STAT3 might operate through an MDA5-dependent manner. STAT3 also appeared to suppress IFN response directly in a manner dependent on its N-terminal domain and independent of its function as a transcriptional factor. Taken together, these results define STAT3 as a negative regulator of type I IFN response and provide a therapeutic target for viral infections.This publication has 38 references indexed in Scilit:
- Signal Transducer and Activator of Transcription‐3, Inflammation, and CancerAnnals of the New York Academy of Sciences, 2009
- Mitochondrial STAT3 Supports Ras-Dependent Oncogenic TransformationScience, 2009
- Acetylation and activation of STAT3 mediated by nuclear translocation of CD44The Journal of cell biology, 2009
- Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based ImmunotherapyCancer Research, 2009
- STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral responseJournal of Biomedical Science, 2009
- Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanismsImmunological Reviews, 2008
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- STAT3 positively regulates an early step in B-cell developmentPublished by American Society of Hematology ,2006
- SOCS3 Is a Physiological Negative Regulator for Granulopoiesis and Granulocyte Colony-stimulating Factor Receptor SignalingPublished by Elsevier BV ,2004
- What does Stat3 do?JCI Insight, 2002